Blueprint Medicines

Filed a patent for "compounds and compositions as fgfr3 degraders and uses thereof" on Tue, December 20, 2022

Filed a patent for "solid forms of cdk2 inhibitor" on Wed, January 4, 2023

Filed a patent for "cdk2 inhibitors" on Wed, January 4, 2023

Filed a patent for "cdk2 inhibitors" on Wed, January 4, 2023

Filed a patent for "cdk2 inhibitors" on Wed, January 4, 2023

Filed a patent for "cdk2 inhibitors for treatment of cancer" on Fri, February 10, 2023

Filed a patent for "wild type kit inhibitors" on Wed, February 15, 2023

Filed a patent for "cdk2 inhibitors" on Fri, April 14, 2023

Filed a patent for "gsk3a inhibitors and methods of use thereof" on Wed, May 10, 2023

Filed a patent for "compounds and compositions as fgfr3 degraders and uses thereof" on Fri, May 19, 2023

Filed a patent for "cdk2 inhibitors for treatment of cancer" on Thu, June 1, 2023

Filed a patent for "gsk3a inhibitors and methods of use thereof" on Fri, August 4, 2023

Filed a patent for "cdk2 inhibitors" on Fri, October 20, 2023

Filed a patent for "inhibitors of ret" on Thu, December 19, 2024

Filed a patent for "cdk2 inhibitors" on Wed, March 13, 2024

Filed a patent for "methods for treating systemic mastocytosis and gastrointestinal stromal tumors" on Thu, November 21, 2024

Filed a patent for "cdk2 inhibitors" on Thu, November 21, 2024

Filed a patent for "compositions useful for treating disorders related to kit" on Thu, September 26, 2024

Filed a patent for "wild type kit inhibitors" on Thu, August 8, 2024

Filed a patent for "cdk2 inhibitors" on Thu, May 25, 2023

Filed a patent for "map4k1 inhibitors" on Thu, April 13, 2023

Filed a patent for "map4k1 inhibitors" on Thu, May 11, 2023

Filed a patent for "egfr inhibitors for treatment of cancer" on Wed, October 19, 2022

Filed a patent for "egfr inhibitors for treatment of cancer" on Tue, November 1, 2022

Filed a patent for "egfr inhibitors for treatment of cancer" on Tue, November 1, 2022